# US 2021/0330627 A1 · Method of using a chlorogenic acid composition for supporting cognitive function

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330627 A1
- Document ID: US20210330627A1
- Status: Published application
- Kind: A1
- Application number: 17/227,296
- Filed: 2021-04-10
- Published: 2021-10-28
- Earliest claimed: 2016-07-12
- Assignees: Vidya Herbs, Inc.
- Applicants: Vidya Herbs, Inc.
- Inventors: Kodimule Shyam PRASAD
- Web page: https://patentgrep.com/patent/US20210330627A1

## CPC

- A61K 31/216: of acids having aromatic rings, e.g. benactizyne, clofibrate
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 36/28: Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention provides compositions comprising chlorogenic acid and methods for their use and manufacture in the treatment of Alzheimer's disease. The compositions can be formulated from botanical sources of chlorogenic acid including sunflower seed extract.

## Claims

### Claim at position 1

1-27. (canceled)

### Claim 28

A method for promoting cognitive function, comprising administering to a person in need thereof an effective amount of a composition comprising sunflower seed extract obtained from aqueous extraction of sunflower seeds, wherein said extract comprises a mixture of chlorogenic acids consisting of 4.1±1.42 w/w % 3-Caffeoylquinic acid (3-CQA), 28±4.65 w/w % 5-Caffeoylquinic acid (5-CQA), 6.5±2.25 w/w % 4-Caffeoylquinic acid (4-CQA), 0.84±0.26 w/w % 3,4-Dicaffeoylquinic acid (3,4-DiCQA), 1.23±0.34 w/w % 3,5-Dicaffeoylquinic acid (3,5-DiCQA), and 1.85±0.42 w/w % 4,5-Dicaffeoylquinic acid (4,5-DiCQA).

### Claim 29 (depends on 28)

The method of claim 28, wherein said composition is administered to said person at a dosage of about 200-400 mg per kilogram body weight.

### Claim 30 (depends on 28)

The method of claim 28, wherein said composition is administered to said person orally.

### Claim 31 (depends on 28)

The method of claim 28, wherein said composition has a DPPH IC50 value of about 38.49 μg/mL in vitro.

### Claim 32 (depends on 28)

The method of claim 28, wherein said composition has an acetylcholinesterase IC50 value of about 43 μg/mL in vitro.

### Claim 33 (depends on 28)

The method of claim 28, wherein said composition is in a form selected from the group consisting of a powder, liquid, pill, tablet, pellet, capsule, thin film, solution, spray, syrup, linctus, lozenge, pastille, chewing gum, paste, vapor, suspension, emulsion, ointment, cream, lotion, liniment, gel, drop, topical patch, buccal patch, bead, gummy, gel, sol, and injectable solution.

### Claim 34 (depends on 28)

The method of claim 28, wherein administering said composition inhibits Tau phosphorylation in said person.

### Claim 35 (depends on 28)

The method of claim 28, wherein administering said composition inhibits the formation of amyloid plaques in said person.

### Claim 36 (depends on 28)

The method of claim 28, wherein administering said composition inhibits the formation of neurofibrillary tangles in said person.

### Claim 37 (depends on 28)

The method of claim 28, wherein administering said composition inhibits the loss of GSH in said person.

### Claim 38 (depends on 28)

The method of claim 28, wherein administering said composition increases GSH in said person.

### Claim 39 (depends on 28)

The method of claim 28, wherein said composition further comprises an excipient.
